Myriad Genetics Sponsors Cancer Awareness Initiatives In Support Of National Hereditary Breast And Ovarian Cancer Week

SALT LAKE CITY, Oct. 3, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that, in support of National Hereditary Breast and Ovarian Cancer (HBOC) Week and National Previvor Day, it has launched an online quiz to help people assess their risk for hereditary cancers. The Hereditary Cancer Quiz is available online at www.hereditarycancerquiz.com . In addition, the company is providing financial support toward educational and awareness initiatives to three advocacy organizations-Bright Pink, the National Ovarian Cancer Coalition (NOCC) and Living Beyond Breast Cancer (LBBC).

HBOC Week marks the transition between National Ovarian Cancer Awareness Month and National Breast Cancer Awareness Month and was established by U.S. Congressional resolution in 2010 to raise awareness about hereditary cancer. National Previvor Day raises awareness for those individuals who have a known gene mutation or a strong family history of cancer but have not yet developed cancer.

"Understanding their risk for hereditary cancers, such as breast and ovarian cancer, is critical to helping patients make informed decisions about treatment and prevention. Our hereditary cancer risk quiz empowers patients to understand their family history and provides a framework for an informative discussion with a healthcare professional," said Mark Capone, President, Myriad Genetic Laboratories. "In addition, organizations such as Bright Pink, NOCC and Living Beyond Breast Cancer offer hereditary cancer patients and their families vital support and information in their fight against these diseases, and we are proud to support their efforts."

"Funding from Myriad and our other partner companies assists our organization in offering better and more valuable resources to hereditary cancer patients and their families," said David Barley, Chief Executive Officer, National Ovarian Cancer Coalition. "We are proud to work with Myriad, as they play a major role in the understanding and diagnosis of a person's hereditary risk for cancer."

1 2 Next › Last »